Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 225

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-23-2_015

تاریخ نمایه سازی: 27 مرداد 1399

Abstract:

Objective(s): Bacteriophages are infectious replicating entities that are under consideration as antimicrobial bioagents to control bacterial infections. As an alternative or supplement to antibiotics, bacteriophages can be used to circumvent the resistance to existing antibiotics. The aim of this study was to assess the synergistic effect of a naturally isolated phage and ampicillin against Escherichia coli O157.Materials and Methods: In the present study, a natural phage against E. coli O157 was isolated, the morphology and molecular characteristics of the phage were identified, and the combination of bacteriophage and antibiotic to combat clinically isolated drug-resistant E. coli O157 was evaluated. Results: The results showed the synergistic action between a naturally isolated phage and ampicillin in solid (disk diffusion test) and liquid culture media. Addition of the isolated phage, gT0E.co-MGY2, to the microbial lawn of bacteria in modified antibiotic disk diffusion test, altered susceptibility pattern of E. coli O157 from resistant to sensitive based on the inhibition zones. Combinations of bacteriophage and ampicillin significantly enhanced the killing of bacterial strains when compared to treatment with ampicillin or phage alone in liquid culture. Moreover, it lasted few hours for ampicillin to reverse the growth of E. coli O157, while the bacteriophage and combination treatment stopped the proliferation of bacteria from the beginning, and this can compensate the delayed onset of antibiotic action.Conclusion: The synergistic action of bacteriophages and antibiotics is an alternative that cannot only be effective against bacterial infections but also contribute to the reduction of antibiotic resistance.

Keywords:

Antibiotic resistance Escherichia coli O157 , Lytic phage , Phage therapy , Synergy , Ampicillin

Authors

Zahra Moradpour

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran|Cellular and Molecular Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran

Nesa Yousefi

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran

Dorna Sadeghi

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran

Abdollah Ghasemian

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran|Cellular and Molecular Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Dalmasso M, Strain R, Neve H, Franz CM, Cousin FJ, ...
  • Ghasemian A, Bavand M, Moradpour Z. A broad-host range coliphage ...
  • Moradpour Z, Sepehrizadeh Z, Rahbarizadeh F, Ghasemian A, Yazdi MT, ...
  • Moradpour Z, Ghasemian A. Isolation and identification of a natural ...
  • Oloketuyi SF, Khan F. Inhibition strategies of Listeria monocytogenes biofilms-current ...
  • Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, ...
  • Oliveira H, Sillankorva S, Merabishvili M, Kluskens LD, Azeredo J. ...
  • Örmälä A-M, Jalasvuori M. Phage therapy: should bacterial resistance to ...
  • Comeau AM, Tétart F, Trojet SN, Prere M-F, Krisch H. ...
  • Torres-Barceló C, Hochberg ME. Evolutionary rationale for phages as complements ...
  • Henry M, Biswas B, Vincent L, Mokashi V, Schuch R, ...
  • Ryan EM, Alkawareek MY, Donnelly RF, Gilmore BF. Synergistic phage-antibiotic ...
  • Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing ...
  • Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet 1998; 352:1207-1212. ...
  • Kitov PI, Sadowska JM, Mulvey G, Armstrong GD, Ling H, ...
  • Paton AW, Morona R, Paton JC. A new biological agent ...
  • Judge NA, Mason HS, O’Brien AD. Plant cell-based intimin vaccine ...
  • Moradpour Z, Ghasemian A. Modified phages: novel antimicrobial agents to ...
  • Laemmli UK. Cleavage of structural proteins during the assembly of ...
  • San Martín C, Huiskonen JT, Bamford JK, Butcher SJ, Fuller ...
  • Patel J, Cockerill F, Alder J, Bradford P, Eliopoulos G, ...
  • Jo A, Kim J, Ding T, Ahn J. Role of ...
  • Uddin MJ, Easwaran M, Ahn J. Characterization of bacteriophages specificity ...
  • Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B, Delattre AS, Lavigne R. ...
  • Ackermann HW. Phage classification and characterization. Methods Mol Biol 2009; ...
  • Jo A, Ding T, Ahn J. Synergistic antimicrobial activity of ...
  • Torres-Barceló C, Arias-Sánchez FI, Vasse M, Ramsayer J, Kaltz O, ...
  • Kamal F, Dennis JJ. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): ...
  • Melo LD, Veiga P, Cerca N, Kropinski AM, Almeida C, ...
  • Summers WC. Bacteriophage therapy. Annu Rev Microbiol 2001; 55:437-451. ...
  • Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, ...
  • نمایش کامل مراجع